# A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

> **NCT00601016** · PHASE2 · COMPLETED · sponsor: **St. Justine's Hospital** · enrollment: 18 (actual)

## Conditions studied

- Hemangioma, Capillary

## Interventions

- **DRUG:** Imiquimod 5% cream

## Key facts

- **NCT ID:** NCT00601016
- **Lead sponsor:** St. Justine's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2008-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00601016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00601016, "A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00601016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*